Relation of red cell distribution width with CHA2DS2-VASc score in patients with nonvalvular atrial fibrillation

Clinical and Applied Thrombosis/Hemostasis

Volumn 20, Issue 7, 2014, Pages 687-692

  Kurt, Mustafa ^a   Tanboga, Ibrahim Halil ^b   Buyukkaya, Eyup ^a   Karakas, Mehmet Fatih ^a   Akçay, Adnan Burak ^a   Sen, Nihat ^a  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

^b ATATÜRK UNIVERSITY   (Turkey)

Author keywords

Atherosclerosis; Atrial fibrillation; Blood cell count; Coronary artery disease; Erythrocyte indices; Risk assessment; Stroke; Thromboembolism

Indexed keywords

HEMOGLOBIN;

AGED; ARTICLE; CHA2DS2 VASC SCORE; ERYTHROCYTE VOLUME; FEMALE; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VOLUME; HUMAN; LEFT ATRIAL VOLUME INDEX; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; THROMBOEMBOLISM; ATRIAL FIBRILLATION; BLOOD; CLINICAL TRIAL; COMPLICATION; HEART STROKE VOLUME; MEAN CORPUSCULAR VOLUME; MIDDLE AGED; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY;

AGED; ATRIAL FIBRILLATION; ERYTHROCYTE INDICES; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MEAN PLATELET VOLUME; MIDDLE AGED; PLATELET COUNT; RETROSPECTIVE STUDIES; STROKE VOLUME; THROMBOEMBOLISM;

EID: 84920512358     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029613478157     Document Type: Article

References (30)

1. Wolf PA, Benjamin EJ, Belanger AJ, Kannel WB, Levy D, D'Agostino RB. Secular trends in the prevalence of atrial fibrillation: The Framingham Study. Am Heart J. 1996; 131(4):790-795.
2. Schnabel RB, Sullivan LM, Levy D, et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet. 2009;373(9665):739-745.
3. Wang TJ, Massaro JM, Levy D, et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA. 2003; 290(8):1049-1056.
4. Chamberlain AM, Agarwal SK, Folsom AR, et al. A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the Atherosclerosis Risk in Communities [ARIC] study). Am J Cardiol. 2011;107(1):85-91.
5. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137(2): 263-272.
6. Horne BD. A changing focus on the red cell distribution width: why does it predict mortality and other adverse medical outcomes? Cardiology. 2012;122(4):213-215.
7. Zalawadiya SK, Veeranna V, Panaich SS, Afonso L, Ghali JK. Gender and ethnic differences in red cell distribution width and its association with mortality among low risk healthy United state adults. Am J Cardiol. 2012;109(11):1664-1670.
8. Isik T, Uyarel H, Tanboga IH, et al. Relation of red cell distribution width with the presence, severity, and complexity of coronary artery disease. Coron Artery Dis. 2012;23(1):51-56.
9. Isik T, Kurt M, Ayhan E, Tanboga IH, Ergelen M, Uyarel H. The impact of admission red cell distribution width on the development of poor myocardial perfusion after primary percutaneous intervention. Atherosclerosis. 2012;224(1):143-149.
10. Ani C, Ovbiagele B. Elevated red blood cell distribution width predicts mortality in persons with known stroke. J Neurol Sci. 2009;277(1-2):103-108.
11. Cauthen CA, Tong W, Jain A, Tang WH. Progressive rise in red cell distribution width is associated with disease progression in ambulatory patients with chronic heart failure. J Card Fail. 2012;18(2):146-152.
12. Tanindi A, Topal FE, Topal F, Celik B. Red cell distribution width in patients with prehypertension and hypertension. Blood Press. 2012;21(3):177-181.
13. Sanchez-Chaparro MA, Calvo-Bonacho E, Gonzalez-Quintela A, et al. Higher red blood cell distribution width is associated with the metabolic syndrome: results of the Ibermutuamur CArdiovascular RIsk assessment study. Diabetes Care. 2010; 33(3):e40.
14. Horne BD, May HT, Kfoury AG, et al. The Intermountain Risk Score (including the red cell distribution width) predicts heart failure and other morbidity endpoints. Eur J Heart Fail. 2010; 12(11):1203-1213.
15. Camm AJ, Kirchhof P, Lip GY, Schotten U, et al. Guidelines for the management of atrial fibrillation: the Task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Europace. 2010;12(10):1360-1420.
16. Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31(19):2369-2429.
17. Armstrong WF, Ryan T, Feigenbaum H. Feigenbaum's Echocardiography. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2010:xv,785.
18. Lloyd-Jones DM, Wang TJ, Leip EP, et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004;110(9):1042-1046.
19. Go AS, Hylek EM, Chang Y, et al. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA. 2003;290(20): 2685-2692.
20. Singer DE, Chang Y, Fang MC, et al. The net clinical benefit of warfarin anticoagulation in atrial fibrillation. Ann Intern Med. 2009;151(5):297-305.
21. Camm AJ, Lip GY, De Caterina R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation ∗ Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33(21): 2719-2747.
22. Chung MK, Martin DO, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation. 2001; 104(24):2886-2891.
23. Sadanaga T, Kohsaka S, Mitamura H, Ogawa S. Elevated B-type natriuretic peptide level as a marker of subsequent thromboembolic events in patients with atrial fibrillation. Heart Vessels. 2011;26(5):530-535.
24. Celebi OO, Celebi S, Canbay A, Ergun G, Aydogdu S, Diker E. The effect of sinus rhythm restoration on high-sensitivity C-reactive protein levels and their association with long-term atrial fibrillation recurrence after electrical cardioversion. Cardiology. 2011;118(3):168-174.
25. Arad M, Shotan A, Weinberger A, Aurbach I, Rabinowitz B. Plasma atrial natriuretic peptide levels for predicting the outcome of atrial fibrillation. Cardiology. 2001;95(2):74-79.
26. Fukuta H, Ohte N, Mukai S, et al. Elevated plasma levels of B-type natriuretic peptide but not C-reactive protein are associated with higher red cell distribution width in patients with coronary artery disease. Int Heart J. 2009;50(3):301-312.
27. Lappe JM, Horne BD, Shah SH, et al. Red cell distribution width, C-reactive protein, the complete blood count, and mortality in patients with coronary disease and a normal comparison population. Clin Chim Acta. 2011;412(23-24):2094-2099.
28. Azab B, Torbey E, Hatoum H, et al. Usefulness of red cell distribution width in predicting all-cause long-term mortality after non-ST-elevation myocardial infarction. Cardiology. 2011;119(2): 72-80.
29. Makhoul BF, Khourieh A, Kaplan M, Bahouth F, Aronson D, Azzam ZS. Relation between changes in red cell distribution width and clinical outcomes in acute decompensated heart failure. Int J Cardiol. In press.
30. Oh J, Kang SM, Won H, et al. Prognostic value of change in red cell distribution width 1 month after discharge in acute decompensated heart failure patients. Circ J. 2012;76(1):109-116.